We are an international group of biotechnology companies with expertise in immunodiagnostics, molecular diagnostics, and radio-immunodiagnostics. Founded in 1992 in the Czech Republic, we have grown from a local company into a global innovator with in-house research, development, and production of in-vitro diagnostic (IVD) products, supported by an international distribution network.

Our strategy is anchored by three key projects – CLIA, MBA, and NGS – focusing our innovation and delivery across next-generation sequencing, chemiluminescent immunoassays, and Microblot-Array. By combining scientific excellence, strong innovation capacity, and a presence in more than 100 markets worldwide, we deliver solutions that advance laboratory practice and patient care, making us one of the key players in clinical diagnostics.

For more information visit our website: www.biovendor.group